Omnibus spending bill features funding to bolster the supply chain and site inspections
After committing about $2 billion for new biomanufacturing efforts, next year’s $1.7 trillion government spending bill features new pharma manufacturing efforts.
In addition to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.